Amelioration of diabetes by imatinib mesylate (Gleevec®): role of ‐cell NF‐KB activation and anti‐apoptotic preconditioning
Year: 2006
Type: article
Source: The FASEB Journal
Institution: Uppsala University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Vetenskapsrådet
OpenAlex ID: W1993124906
